Bridge Global Pharmaceutical Services Inc is categorized under Medical Research in Gaithersburg, MD and active since 2006.
Bridge Global Pharmaceutical Services Inc was established in 2006, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Thomas Oakley at the company’s headquarters by writing to 610 Professional Drive, Gaithersburg, Maryland MD 20879 or by phoning (240) 364-6428. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bridge Global Pharmaceutical Services Inc |
| Contact Person: | Thomas Oakley |
| Address: | 610 Professional Drive, Gaithersburg, Maryland 20879 |
| Phone Number: | (240) 364-6428 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2006 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Bridge Global Pharmaceutical Services Inc was started in 2006 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Thomas Oakley for inquiries that concern Bridge Global Pharmaceutical Services Inc by calling the company number (240) 364-6428, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Bridge Global Pharmaceutical Services Inc can be found at the coordinates 39.162717,-77.228186 as well as the street address 610 Professional Drive in Gaithersburg, Maryland 20879.
For its online presence, you may visit Bridge Global Pharmaceutical Services Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.